Therapeutic Drug Monitoring of Non-Anti-Tumor Necrosis Factor Biologics

Clin Gastroenterol Hepatol. 2021 Jun;19(6):1108-1110. doi: 10.1016/j.cgh.2021.01.002. Epub 2021 Feb 6.

Authors

Richa Shukla¹, Ashwin Ananthakrishnan²

Affiliations

¹ Baylor College of Medicine, Houston, Texas.
² Division of Gastroenterology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.

PMID: 33556336
DOI: 10.1016/j.cgh.2021.01.002

No abstract available

Publication types

Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't

MeSH terms

Biological Factors
Biological Products*
Drug Monitoring
Humans
Infliximab / adverse effects
Tumor Necrosis Factor-alpha

Substances

Biological Factors
Biological Products
Tumor Necrosis Factor-alpha
Infliximab